Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure

Metabolomics

Volumn 9, Issue 2, 2013, Pages 392-402

  McClay, Joseph L ^a   Adkins, Daniel E ^a   Vunck, Sarah A ^b   Batman, Angela M ^a   Vann, Robert E ^a   Clark, Shaunna L ^a   Beardsley, Patrick M ^a   van den Oord, Edwin J C G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Drugs of abuse; Inbred mice; Mass spectrometry; Neurotoxicity; Psychostimulants

Indexed keywords

2 HYDROXYGLUTARIC ACID; LACTIC ACID; METHAMPHETAMINE; PHOSPHORYLCHOLINE; SUCCINIC ACID; THIONEINE; TRYPTOPHAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN MITOCHONDRION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; ENERGY METABOLISM; LOCOMOTION; LONG TERM EXPOSURE; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; MOUSE; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; QUANTITATIVE ANALYSIS;

MUS; RODENTIA;

EID: 84875486181     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0456-y     Document Type: Article

References (67)

1. Akanmu, D., Cecchini, R., Aruoma, O. I., & Halliwell, B. (1991). The antioxidant action of ergothioneine. Archives of Biochemistry and Biophysics, 288, 10-16.
2. Ariyannur, P. S., Moffett, J. R., Manickam, P., et al. (2010). Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Research, 1335, 1-13.
3. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B, 57, 289-300.
4. Bukszar, J., McClay, J. L., & van den Oord, E. J. (2009). Estimating the posterior probability that genome-wide association findings are true or false. Bioinformatics, 25, 1807-1813.
5. Caligiuri, M. P., & Buitenhuys, C. (2005). Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? Neuropsychopharmacology, 30, 2125-2134.
6. Carvalho, M., Carmo, H., Costa, V. M., et al. (2012). Toxicity of amphetamines: An update. Archives of Toxicology, 86(8), 1167-1231.
7. Chang, L., Ernst, T., Speck, O., & Grob, C. S. (2005). Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. American Journal of Psychiatry, 162, 361-369.
8. Clayton, T. A., Lindon, J. C., Cloarec, O., et al. (2006). Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature, 440, 1073-1077.
9. Constantinou, C., Chrysanthopoulos, P. K., Margarity, M., & Klapa, M. I. (2011). GC-MS metabolomic analysis reveals significant alterations in cerebellar metabolic physiology in a mouse model of adult onset hypothyroidism. Journal of Proteome Research, 10, 869-879.
10. Curtis, E. K. (2006). Meth mouth: a review of methamphetamine abuse and its oral manifestations. General Dentistry, 54, 125-129. quiz 130.
11. de Graaf, R. A., Chowdhury, G. M., Brown, P. B., Rothman, D. L., & Behar, K. L. (2009). In situ 3D magnetic resonance metabolic imaging of microwave-irradiated rodent brain: A new tool for metabolomics research. Journal of Neurochemistry, 109, 494-501.
12. Dehaven, C. D., Evans, A. M., Dai, H., & Lawton, K. A. (2010). Organization of GC/MS and LC/MS metabolomics data into chemical libraries. Journal of Cheminformatics, 2, 9.
13. Ernst, T., Chang, L., Leonido-Yee, M., & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology, 54, 1344-1349.
14. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009). Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical Chemistry, 81, 6656-6667.
15. Gonzales, R., Mooney, L., & Rawson, R. A. (2010). The methamphetamine problem in the United States. Annual Review of Public Health, 31, 385-398.
16. Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G., & Kell, D. B. (2004). Metabolomics by numbers: Acquiring and understanding global metabolite data. Trends in Biotechnology, 22, 245-252.
17. Grundemann, D., Harlfinger, S., Golz, S., et al. (2005). Discovery of the ergothioneine transporter. Proceedings of National Academy of Sciences of the United States of America, 102, 5256-5261.
18. Hendrickson, R. G., Cloutier, R., & McConnell, K. J. (2008). Methamphetamine-related emergency department utilization and cost. Academic Emergency Medicine, 15, 23-31.
19. Ikarashi, Y., Sasahara, T., & Maruyama, Y. (1985). Postmortem changes in catecholamines, indoleamines, and their metabolites in rat brain regions: Prevention with 10-kW microwave irradiation. Journal of Neurochemistry, 45, 935-939.
20. Kaddurah-Daouk, R., & Krishnan, K. R. (2009). Metabolomics: A global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology, 34, 173-186.
21. Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008). Metabolomics: A global biochemical approach to drug response and disease. Annual Review of Pharmacology and Toxicology, 48, 653-683.
22. Karila, L., Weinstein, A., Aubin, H. J., Benyamina, A., Reynaud, M., & Batki, S. L. (2010). Pharmacological approaches to methamphetamine dependence: A focused review. British Journal of Clinical Pharmacology, 69, 578-592.
23. Kasischke, K. A., Vishwasrao, H. D., Fisher, P. J., Zipfel, W. R., & Webb, W. W. (2004). Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science, 305, 99-103.
24. Kaye, S., McKetin, R., Duflou, J., & Darke, S. (2007). Methamphetamine and cardiovascular pathology: A review of the evidence. Addiction, 102, 1204-1211.
25. Kita, T., Miyazaki, I., Asanuma, M., Takeshima, M., & Wagner, G. C. (2009). Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. International Review of Neurobiology, 88, 43-64.
26. Kopp, F., Komatsu, T., Nomura, D. K., et al. (2010). The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice. Chemistry and Biology, 17, 831-840.
27. Krasnova, I. N., & Cadet, J. L. (2009). Methamphetamine toxicity and messengers of death. Brain Research Reviews, 60, 379-407.
28. Lee, D. W., Kim, S. Y., Lee, T., et al. (2012). Ex vivo detection for chronic ethanol consumption-induced neurochemical changes in rats. Brain Research, 1429, 134-144.
29. Li, Z., & Vance, D. E. (2008). Phosphatidylcholine and choline homeostasis. Journal of Lipid Research, 49, 1187-1194.
30. Lindon, J. C., Holmes, E., & Nicholson, J. K. (2006). Metabonomics techniques and applications to pharmaceutical research and development. Pharmaceutical Research, 23, 1075-1088.
31. Loftus, N., Barnes, A., Ashton, S., et al. (2011). Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis. Journal of Proteome Research, 10, 705-713.
32. Login, G. R., & Dvorak, A. M. (1994). Application of microwave fixation techniques in pathology to neuroscience studies: A review. Journal of Neuroscience Methods, 55, 173-182.
33. McLoughlin, G. A., Ma, D., Tsang, T. M., et al. (2009). Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. Journal of Proteome Research, 8, 1943-1952.
34. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. (2007). N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Progress in Neurobiology, 81, 89-131.
35. Moncaster, J. A., Walsh, D. T., Gentleman, S. M., Jen, L. S., & Aruoma, O. I. (2002). Ergothioneine treatment protects neurons against N-methyl-d-aspartate excitotoxicity in an in vivo rat retinal model. Neuroscience Letters, 328, 55-59.
36. Nicosia, N., Pacula, R. L., Kilmer, B., Lundberg, R., Chiesa, J. (2009). The Economic Cost of Methamphetamine Use in the United States, 2005.
37. Nomura, D. K., Morrison, B. E., Blankman, J. L., et al. (2011). Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science, 334, 809-813.
38. Ohta, T., Masutomi, N., Tsutsui, N., et al. (2009). Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicologic Pathology, 37, 521-535.
39. Pan, Z., & Raftery, D. (2007). Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry, 387, 525-527.
40. Parng, C., Ton, C., Lin, Y. X., Roy, N. M., & McGrath, P. (2006). A zebrafish assay for identifying neuroprotectants in vivo. Neurotoxicology and Teratology, 28, 509-516.
41. Patkar, A. A., Rozen, S., Mannelli, P., et al. (2009). Alterations in tryptophan and purine metabolism in cocaine addiction: A metabolomic study. Psychopharmacology (Berl), 206, 479-489.
42. Peachey, E., Rogers, B., Brien, J. F., Maclean, A., & Rogers, D. (1976). Measurement of acute and chronic behavioural effects of methamphetamine in the mouse. Psychopharmacology (Berl), 48, 271-275.
43. Perrine, S. A., Michaels, M. S., Ghoddoussi, F., Hyde, E. M., Tancer, M. E., & Galloway, M. P. (2009). Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR in Biomedicine, 22, 419-425.
44. Petkov, P. M., Ding, Y., Cassell, M. A., et al. (2004). An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Research, 14, 1806-1811.
45. Reglinski, J., Smith, W. E., & Sturrock, R. D. (1988). Spin-echo 1H NMR detected response of ergothioneine to oxidative stress in the intact human erythrocyte. Magnetic Resonance in Medicine, 6, 217-223.
46. Ross, B. M., Moszczynska, A., Peretti, F. J., et al. (2002). Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence, 67, 73-79.
47. Salo, R., Buonocore, M. H., Leamon, M., et al. (2011). Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study. Drug and Alcohol Dependence, 113, 133-138.
48. Salo, R., Nordahl, T. E., Natsuaki, Y., et al. (2007). Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry, 61, 1272-1280.
49. Searle, S. R. (1971). Linear models. New York: Wiley.
50. Searle, S. R., Casella, G., & McCulloch, C. E. (1992). Variance components. New York: Wiley.
51. Shi, X., Yao, D., & Chen, C. (2012). Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. Journal of Biological Chemistry, 287, 6336-6349.
52. Shiba, T., Yamato, M., Kudo, W., Watanabe, T., Utsumi, H., & Yamada, K. (2011). In vivo imaging of mitochondrial function in methamphetamine-treated rats. Neuroimage, 57, 866-872.
53. Shima, N., Miyawaki, I., Bando, K., et al. (2011). Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology, 287, 29-37.
54. Storey, J. (2003). The positive false discovery rate: A Bayesian interpretation and the q value. Annals of Statistics, 31, 2013-2035.
55. Substance Abuse and Mental Health Services Administration (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings NSDUH Series H-38A. Rockville, MD: Office of Applied Studies.
56. Sylvia, A. L., LaManna, J. C., Rosenthal, M., & Jobbis, F. F. (1977). Metabolite studies of methamphetamine effects based upon mitochondrial respiratory state in rat brain. Journal of Pharmacology and Experimental Therapeutics, 201, 117-125.
57. van den Oord, E., & Sullivan, P. F. (2003). False discoveries and models for gene discovery. Trends in Genetics, 19, 537-542.
58. van Schaftingen, E., Rzem, R., & Veiga-da-Cunha, M. (2009). L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. Journal of Inherited Metabolic Disease, 32, 135-142.
59. Volz, T. J., Fleckenstein, A. E., & Hanson, G. R. (2007). Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction, 102(Suppl 1), 44-48.
60. Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
61. Wishart, D. S. (2007). Current progress in computational metabolomics. Brief Bioinformatics, 8, 279-293.
62. Xia, J., & Wishart, D. S. (2010). MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Research, 38, W71-W77.
63. Xia, J., & Wishart, D. S. (2011). Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nature Protocols, 6, 743-760.
64. Yamamoto, B. K., & Bankson, M. G. (2005). Amphetamine neurotoxicity: Cause and consequence of oxidative stress. Critical Reviews in Neurobiology, 17, 87-117.
65. Yamamoto, B. K., Moszczynska, A., & Gudelsky, G. A. (2010). Amphetamine toxicities: Classical and emerging mechanisms. Annals of the New York Academy of Sciences, 1187, 101-121.
66. Yoon, S. J., Lyoo, I. K., Kim, H. J., et al. (2010). Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5′-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology, 35, 1165-1173.
67. Zweben, J. E., Cohen, J. B., Christian, D., et al. (2004). Psychiatric symptoms in methamphetamine users. American Journal of Addictions, 13, 181-190.